MO50-6 Characterization of patients with advanced biliary tract cancer by KRAS alteration subtypesTaro Shibuki, Masato Ikeda, Yuichi Nakamura et al.|Annals of Oncology|2024Cited by 0
Use of transcriptomic signatures of <i>RAD51</i> and <i>GATA6</i> to predict real-world overall survival with platinum therapy in <i>BRCA/PALB2</i> wild-type metastatic pancreatic cancer.Binbin Zheng-Lin, Tanios S. Bekaii-Saab, Ellen Jaeger et al.|Journal of Clinical Oncology|2026Cited by 0
Prognostic role of PIK3CA and co-alterations in advanced biliary tract cancer: A multicenter retrospective analysis.Oluseyi Abidoye, Tanios S. Bekaii-Saab, Daniel H. Ahn et al.|Journal of Clinical Oncology|2026Cited by 0